Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Eva M Garrido-Martin"'
Autor:
Fernando López-Ríos, Luis Paz-Ares, Pilar Garrido, Eva M Garrido-Martin, Jose Palacios, Elena Sanchez, Ana Belén Enguita, Javier Ramos-Paradas, Susana Hernández-Prieto, David Lora, Aranzazu Rosado, Tamara Caniego-Casas, Nuria Carrizo, María Teresa Muñoz-Jimenez, Borja Rodriguez, Urbicio Perez-Gonzalez, David Gómez-Sánchez, Irene Ferrer, Santiago Ponce Aix, Ángel Nuñez Buiza
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background Tumor mutational burden (TMB) is a recently proposed predictive biomarker for immunotherapy in solid tumors, including non-small cell lung cancer (NSCLC). Available assays for TMB determination differ in horizontal coverage, gene content a
Externí odkaz:
https://doaj.org/article/a0e4de9a317e425992c6330eeb6a0581
Autor:
Anaïs Jiménez-Reinoso, Magdalena Molero-Abraham, Cristina Cirauqui, Belén Blanco, Eva M. Garrido-Martin, Daniel Nehme-Álvarez, Carmen Domínguez-Alonso, Ángel Ramírez-Fernández, Laura Díez-Alonso, Ángel Nuñez-Buiza, África González-Murillo, Raquel Tobes, Eduardo Pareja, Manuel Ramírez-Orellana, José Luis Rodriguez-Peralto, Irene Ferrer, Jon Zugazagoitia, Luis Paz-Ares, Luis Álvarez-Vallina
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Adoptive transfer of tumor-infiltrating lymphocytes (TIL) has shown remarkable results in melanoma, but only modest clinical benefits in other cancers, even after TIL have been genetically modified to improve their tumor homing, cytotoxic potential o
Externí odkaz:
https://doaj.org/article/e8672f59553649e1a19d8ee020cd28b0
Autor:
Eun-Jung Choi, Yong Hwan Kim, Se-woon Choe, Yu Gyoung Tak, Eva M Garrido-Martin, Myron Chang, Young Jae Lee, S Paul Oh
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63138 (2013)
Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic vascular disease in which arteriovenous malformations (AVMs) manifest in skin and multiple visceral organs. HHT is caused by heterozygous mutations in endoglin (ENG), activin receptor-like kina
Externí odkaz:
https://doaj.org/article/73e0d6d637c245668eb8248f394a17c3
Autor:
Luis Alvarez-Vallina, Laura Sanz, Luis Paz-Ares, José L. Rodriguez-Peralto, Ignacio Melero, Ines G. Muñoz, Miguel A. Morcillo, Francisco J. Blanco, Angel Ramírez-Fernández, Manuela Zonca, Carmen Domínguez-Alonso, Oana Hangiu, Daniel Nehme-Álvarez, Nekane Merino, Marta Oteo, Belén Blanco, Maria C. Ochoa, Ana B. Enguita, Eva M. Garrido-Martin, Irene Ferrer, Eduardo Romero, Antonio Tapia-Galisteo, Ainhoa Erce-Llamazares, Seandean L. Harwood, Marta Compte
Structural and functional characterization of 4-1BBN/CEGFR after conjugation with p-SCN-Bn-deferoxamine (Df).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b3945f0c7eb0bace17584c12704fcea
https://doi.org/10.1158/1078-0432.22479489.v1
https://doi.org/10.1158/1078-0432.22479489.v1
Autor:
Luis Alvarez-Vallina, Laura Sanz, Luis Paz-Ares, José L. Rodriguez-Peralto, Ignacio Melero, Ines G. Muñoz, Miguel A. Morcillo, Francisco J. Blanco, Angel Ramírez-Fernández, Manuela Zonca, Carmen Domínguez-Alonso, Oana Hangiu, Daniel Nehme-Álvarez, Nekane Merino, Marta Oteo, Belén Blanco, Maria C. Ochoa, Ana B. Enguita, Eva M. Garrido-Martin, Irene Ferrer, Eduardo Romero, Antonio Tapia-Galisteo, Ainhoa Erce-Llamazares, Seandean L. Harwood, Marta Compte
Oligonucleotides used in this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec019f0e79b48b5fb2d166260477d5fb
https://doi.org/10.1158/1078-0432.22479450
https://doi.org/10.1158/1078-0432.22479450
Autor:
Luis Alvarez-Vallina, Laura Sanz, Luis Paz-Ares, José L. Rodriguez-Peralto, Ignacio Melero, Ines G. Muñoz, Miguel A. Morcillo, Francisco J. Blanco, Angel Ramírez-Fernández, Manuela Zonca, Carmen Domínguez-Alonso, Oana Hangiu, Daniel Nehme-Álvarez, Nekane Merino, Marta Oteo, Belén Blanco, Maria C. Ochoa, Ana B. Enguita, Eva M. Garrido-Martin, Irene Ferrer, Eduardo Romero, Antonio Tapia-Galisteo, Ainhoa Erce-Llamazares, Seandean L. Harwood, Marta Compte
Purpose:The induction of 4-1BB signaling by agonistic antibodies can drive the activation and proliferation of effector T cells and thereby enhance a T-cell–mediated antitumor response. Systemic administration of anti-4-1BB–agonistic IgGs, althou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0301e39e8aab5729f7e31404cf8e54a9
https://doi.org/10.1158/1078-0432.c.6530226
https://doi.org/10.1158/1078-0432.c.6530226
Autor:
Suranga Dharmasiri, Jane E. Collins, Eva M. Garrido-Martin, J R Fraser Cummings, Tilman Sanchez-Elsner, Richard Harris, Adrian C Bateman
Publikováno v:
Inflammatory Bowel Diseases
Background Intestinal macrophages are key immune cells in the maintenance of intestinal immune homeostasis and have a role in the pathogenesis of inflammatory bowel disease (IBD). However, the mechanisms by which macrophages exert a pathological infl
Autor:
Maria Ángela Oliva, Beatriz Álvarez-Bernad, Daniel Lucena-Agell, Marta Martínez Diez, María José Guillén, Gema Santamaría Nuñez, María José Muñoz-Alonso, Eva M. Garrido-Martin, Pablo Avilés, Carmen Cuevas, J. Fernando Díaz
Publikováno v:
Cancer Research. 83:6239-6239
Background: Microtubule targeting compounds are a successful class of anticancer agents in the clinic. Although highly potent, the currently approved antitumor agents targeting tubulin present some drawbacks such as the development of acquired resist
Autor:
Esther Redin, Eva M. Garrido-Martin, Karmele Valencia, Miriam Redrado, Jose Luis Solorzano, Rafael Carias, Mirari Echepare, Francisco Exposito, Diego Serrano, Irene Ferrer, Angel Nunez-Buiza, Irati Garmendia, Juana M. García-Pedrero, Alfonso Gurpide, Luis Paz-Ares, Katerina Politi, Luis M. Montuenga, Alfonso Calvo
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 17(12)
SCLC is an extremely aggressive subtype of lung cancer without approved targeted therapies. Here we identified YES1 as a novel targetable oncogene driving SCLC maintenance and metastasis.Association between YES1 levels and prognosis was evaluated in
Autor:
Javier Ramos-Paradas, David Gómez-Sánchez, Aranzazu Rosado, Alvaro C. Ucero, Irene Ferrer, Ricardo García-Luján, Jon Zugazagoitia, Nuria Carrizo, Ana B. Enguita, Esther Conde, Eva M. Garrido-Martin, Luis Paz-Ares
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 6; Pages: 1500
Lung cancer is the leading cause of cancer mortality worldwide, with non-small cell lung cancer (NSCLC) being the most prevalent histology. While immunotherapy with checkpoint inhibitors has shown outstanding results in NSCLC, the precise identificat